tirzepatide supreme court Compounders can no longer produce Lilly weight-loss copycats FDA shakes up weight loss

The Zepbound prescribing information reports similar findings

Goals, comorbidities, lifestyle, side-effect tolerance, cost, and long-term sustainability are essential topics when deciding whether Tirzepatide is right for you

Users on tirzepatide lose an average of 15-22.5% of body weight versus 10-15% on semaglutide at comparable durations

Only increase to 12.5-15mg if weight loss stalls

These results were shown in Supplementary Figures S7A, B

Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe